Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy

Stereotactic ablative body radiotherapy for lung cancer.

Lung stereotactic ablative radiotherapy (SABR) is a method of delivering high 'ablative' doses of radiotherapy to tumours in the lung. It was developed at the Karolinska Institute in the early 1990s using the methods established in cranial radiosurgery with multiple beams prescribed to an isodose and using a custom designed stereotactic body frame for immobilisation. Since then, aligned with th...

Stereotactic ablative radiotherapy for lung cancer

Stereotactic ablative radiotherapy (SABR), which is also referred to as stereotactic body radiotherapy (SBRT), is defined as “the precise irradiation of an image defined extra-cranial lesion associated with the use of high radiation dose in a small number of fractions”. SABR is a relatively recent advance in the treatment of small peripheral non-small cell lung tumours. The concept of SABR was ...

Historical Development of Stereotactic Ablative Radiotherapy

Stereotactic radiosurgery (SRS) has been an effective modality for the treatment of benign and malignant cranial disease for over 50 years. Just as SRS revolutionized the practice of neurosurgery, stereotactic ablative radiotherapy (SAbR) in extracranial sites is now challenging conventional wisdom with regard to the practice of radiation oncology. This clinical paradigm change has been enabled...

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver

Liver metastasis in solid tumors, including colorectal cancer, is the most frequent and lethal complication. The development of systemic therapy has led to prolonged survival. However, in selected patients with a finite number of discrete lesions in liver, defined as oligometastatic state, additional local therapies such as surgical resection, radiofrequency ablation, cryotherapy, and radiother...

Stereotactic ablative body radiotherapy for hepatocellular carcinoma or cholangiocarcinoma